Description

Zaxotein Injection 100 mg contains Albumin-Bound Paclitaxel (Nab-Paclitaxel) 100 mg, an advanced formulation of the chemotherapy medicine paclitaxel. It belongs to the taxane class of anticancer agents and is designed to interfere with cancer cell division, helping to slow down or stop the growth of malignant cells. Albumin-bound paclitaxel uses an albumin-based delivery system that helps transport paclitaxel to tumor tissues. It is used in the treatment of various solid tumors, including breast cancer, non-small cell lung cancer, pancreatic cancer, and other cancers where taxane therapy is considered appropriate. Zaxotein Injection is administered by intravenous infusion under the supervision of qualified oncology professionals. The dosage schedule is determined by the treating oncologist based on the patient's cancer type, treatment plan, and overall health condition. Key Features: Contains Albumin-Bound Paclitaxel (Nab-Paclitaxel) 100 mg Advanced taxane-based chemotherapy formulation Used in multiple solid tumor treatment protocols Helps inhibit cancer cell growth and division Intravenous formulation for hospital and oncology center use Manufactured under strict pharmaceutical quality standards Suitable for oncology departments, hospitals, and specialized cancer care facilities Therapeutic Uses: Breast Cancer Non-Small Cell Lung Cancer (NSCLC) Pancreatic Cancer Other solid tumors as recommended by an oncologist Note: Zaxotein Injection should only be administered under the supervision of a qualified healthcare professional. Patients require regular monitoring for treatment response and possible chemotherapy-related adverse effects.